Given the strong effector functions harboured by TH9 cells, we believe that the identification of autophagy as a factor dictating IL-9 secretion from TH9 cells provides significant insights to design new therapies not only against cancer but also to alleviate the course of allergic and autoimmune diseases. This evidence concerns the gene IL9 and autoimmune disease.